about
The crystal structure analysis of the relative binding of cisplatin and carboplatin in a mixture with histidine in a protein studied at 100 and 300 K with repeated X-ray irradiationGreen Synthesis, Characterization and Uses of Palladium/Platinum NanoparticlesCarboplatin binding to histidineDisturbance of DNA conformation by the binding of testosterone-based platinum drugs via groove-face and intercalative interactions: a molecular dynamics simulation study.Transferring the concept of multinuclearity to ruthenium complexes for improvement of anticancer activity.DNA-Destabilizing Agents as an Alternative Approach for Targeting DNA: Mechanisms of Action and Cellular ConsequencesCisplatin inhibits protein splicing, suggesting inteins as therapeutic targets in mycobacteria.Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549).Biosynthesized Platinum Nanoparticles Inhibit the Proliferation of Human Lung-Cancer Cells in vitro and Delay the Growth of a Human Lung-Tumor Xenograft in vivo: -In vitro and in vivo Anticancer Activity of bio-Pt NPsFree Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy.Gold(III)-dithiocarbamato peptidomimetics in the forefront of the targeted anticancer therapy: preclinical studies against human breast neoplasia.Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapyIn vitro and in vivo antitumor activities and DNA binding mode of five coordinated cyclometalated organoplatinum(II) complexes containing biphosphine ligands.Small molecules targeting c-Myc oncogene: promising anti-cancer therapeuticsSynthesis, characterization and biological activity of trans-platinum(II) complexes with chloroquine.Hexanuclear self-assembled arene-ruthenium nano-prismatic cages: potential anticancer agents.Comparative In Vitro Binding Studies of TiCl2(dpme)2, Ti(ada)2(bzac)2, and TiCl2(bzac)(bpme) Titanium Complexes with Calf-Thymus DNA.Synthetic polymers as drug-delivery vehicles in medicineDithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells.Comparison of the effects of the oral anticancer platinum(IV) complexes oxoplatin and metabolite cis-diammine-tetrachlorido-platinum(IV) on global gene expression of NCI-H526 cellsNovel metals and metal complexes as platforms for cancer therapyThe binding assessment with human serum albumin of novel six-coordinate Pt(IV) complexes, containing bidentate nitrogen donor/methyl ligandsInteraction of classical platinum agents with the monomeric and dimeric Atox1 proteins: a molecular dynamics simulation study.A Systems Biology Approach to Understanding the Mechanisms of Action of an Alternative Anticancer Compound in Comparison to Cisplatin.Synthesis of [PtCl2(4,4'-dialkoxy-2,2'-bipyridine)] complexes and their in vitro anticancer properties.Synthesis, spectral characterization, and antiproliferative studies of mixed ligand titanium complexes of adamantylamine.Similarities and differences between the "relativistic" triad gold, platinum, and mercury in catalysis.Targeting and delivery of platinum-based anticancer drugs.Clinical developments of chemotherapeutic nanomedicines: polymers and liposomes for delivery of camptothecins and platinum (II) drugs.Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes.Palladium(II) Complexes of Biorelevant Ligands. Synthesis, Structures, Cytotoxicity and Rich DNA/HSA Interaction Studies.Synthesis, characterization, DNA and HSA binding studies of isomeric Pd (II) antitumor complexes using spectrophotometry techniques.Antileukemic action of novel diamine Pt(II) halogenido complexes: Comparison of the representative novel Pt(II) with corresponding Pt(IV) complex.A platinum blue complex exerts its cytotoxic activity via DNA damage and induces apoptosis in cancer cells.Helium-based cold atmospheric plasma-induced reactive oxygen species-mediated apoptotic pathway attenuated by platinum nanoparticles.Methyl 6-Amino-6-deoxy-d-pyranoside-Conjugated Platinum(II) Complexes for Glucose Transporter (GLUT)-Mediated Tumor Targeting: Synthesis, Cytotoxicity, and Cellular Uptake Mechanism.New Look on 3-Hydroxyiminoflavanone and Its Palladium(II) Complex: Crystallographic and Spectroscopic Studies, Theoretical Calculations and Cytotoxic Activity.β-lactoglobulin-pectin Nanoparticle-based Oral Drug Delivery System for Potential Treatment of Colon Cancer.Upregulation of microRNA-375 increases the cisplatin-sensitivity of human gastric cancer cells by regulating ERBB2.Design, Synthesis of Novel Platinum(II) Glycoconjugates, and Evaluation of Their Antitumor Effects.
P2860
Q27683672-6542A66F-2BAE-41F9-80CD-5B8F7A84448DQ28070067-B131AE7D-A7AE-40D2-8B0F-355B72D1163BQ28655961-76945F70-D691-4D3F-82F4-D325727A10CEQ30538107-14337F0A-14A1-4B60-BAC0-29A93EEF144EQ33640724-AABD74F2-3107-4438-A130-FBD013963DDFQ34042848-82CC356F-E1AE-4B83-B002-7445DBBC2991Q34488965-A296101C-8C8B-4CF6-859D-961BBED327EBQ34638253-573D1A08-9F31-4B05-A237-2AB5F461A917Q34677778-812409FF-500F-4776-8A5E-E9D68A9DF60CQ34778423-FEAB3030-F56D-4172-B2A6-04CF1D50FAC5Q35083349-18977FCE-57D3-42EC-B12E-A77332D1B57EQ35128594-FB52AB4D-8786-4F93-AAA1-E00B3932C793Q35216231-E5D37537-0DB0-4767-A71D-44CB572E39D2Q35353405-5E9572E4-0D00-4E29-9FC6-F4A85F718B12Q35803993-03D65932-4C84-4B6A-9448-10C06AC44265Q36232940-AF0A4E6B-23DA-407D-9A07-5C61B497BD1FQ36457231-F195F9E7-A557-49DE-ADB9-9E34729B6195Q36662516-544687D3-1807-4808-844A-99B86B53D801Q36837031-A83B5203-07CD-4889-AB14-8D1C70E7D365Q36890460-115BCCD6-7325-409F-94D6-6FD9720807B6Q37137649-2B6CD824-6256-4FCA-AFE3-E6820E83A278Q37248556-E1FD8DD6-2A3B-4F3F-B9E3-C3947E563887Q37535399-CD25589E-E61F-48B3-B905-E08D2AC5FDF6Q37636367-8D10DDF0-E28C-409D-8F31-02255177A703Q37638249-04FD30E1-D328-4F89-9A4A-1B16D76D71D8Q37639884-C86CC263-40BE-4C89-A2E8-CAD0285C3F88Q37956605-1DA57DB8-1A75-4AFC-9FF8-2EA5A4D55C9FQ38050063-F5A1D3B2-6D3C-40BC-B038-EBA528E820BBQ38075544-AE47908F-76D7-4CA1-A6D3-055306527492Q38203819-33D88341-C894-41F5-8EEE-A9266757CE3CQ38693914-05C1F986-24D9-45E3-A617-1D049DE5AACDQ38706344-81FE0642-22DE-4B7E-84FC-E155E68BD886Q38720587-7538D7D4-1628-4650-ABC4-51700EF95D4AQ38721734-D3661768-2B0E-4CF7-A52B-07D08FDB67BDQ38766885-AA10AEE0-5A17-405C-AD74-7814E9F52F14Q38773938-1F5C6ABE-09B6-4E5F-B91B-A3F5D1B4393BQ38777400-FAE1121D-3FAB-4926-BBDD-EBF46B59BE6AQ38792530-7CB814F6-91F8-4ED8-9176-86C850509C80Q38792755-24A25593-8576-444C-86A4-20EB1508578BQ38808998-33B3BD1D-77BE-4FFD-8AD9-1682C05EB5C6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Platinum complexes as anticancer agents.
@en
Platinum complexes as anticancer agents.
@nl
type
label
Platinum complexes as anticancer agents.
@en
Platinum complexes as anticancer agents.
@nl
prefLabel
Platinum complexes as anticancer agents.
@en
Platinum complexes as anticancer agents.
@nl
P1476
Platinum complexes as anticancer agents.
@en
P2093
Irena Kostova
P356
10.2174/157489206775246458
P577
2006-01-01T00:00:00Z